Glycopyrrolate 0.2 mg/mL
Reason Stability data does not support expiry.
11,815 recalls · Class II, newest first
Reason Stability data does not support expiry.
Reason Stability data does not support expiry.
Reason Stability data does not support expiry.
Reason Stability data does not support expiry.
Reason Stability data does not support expiry.
Reason Stability data does not support expiry.
Reason Subpotent drug.
Reason Stability data does not support expiry.
Reason Stability data does not support expiry.
Reason Stability data does not support expiry.
Reason Subpotent drug.
Reason Stability data does not support expiry.
Reason Failed Stability Specifications: product may not meet specification limit for assay test.
Reason Lack of Assurance of Sterility: Failed preservative effectiveness testing.
Reason Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.
Reason Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.
Reason Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.
Reason Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.
Reason Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.
Reason Presence of Foreign Substance: customer complaint that one unit dose cup contained a small piece of cardboard contaminant.
Reason Chemical contamination: Product may be contaminated with a toxic compound.
Reason Failed Dissolution Specifications
Reason Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in the 1000-count bottle of hydrochlorothiazide 25 mg tablets.
Reason Failed Dissolution Specifications
Reason CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.